Brief: Cingulate Says Initiation Of Pediatric Phase 3 Studies To Commence In July And August
29/06/2023 13:12
June 29 (Reuters) - Cingulate Inc CING.O :
* CINGULATE SUCCESSFULLY MANUFACTURES CLINICAL SUPPLY –
INITIATION
OF PEDIATRIC PHASE 3 STUDIES TO COMMENCE IN JULY AND AUGUST
Source text for Eikon: ID:nGNX2qNHRf
Further company coverage: CING.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cingulate
See all newsBrief: Cingulate Announces Publication Of Phase 3 Adhd Trial Results In Journal Of Child And Adolescent Psychopharmacology
NASDAQ RESUMED AT 09:39 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM
NASDAQ RESUMED AT 08:30 AM
FDA declines to approve Cingulate's ADHD treatment over manufacturing issues (updated)